PRE-STARt Intervention - Trial of an Interactive Family Based Lifestyle Programme

NCT02845791 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 318

Last updated 2019-01-16

No results posted yet for this study

Summary

To investigate whether the interactive family based lifestyle programme leads to behaviour change at 6 months with the primary outcome being increased levels of moderate to vigorous physical activity (MVPA).

Conditions

Interventions

BEHAVIORAL

Interactive Lifestyle programme workshop

Participants will attend eight 90 minute sessions of an interactive lifestyle programme along with their parent(s)/guardian(s).

Sponsors & Collaborators

  • University of Leicester

    collaborator OTHER
  • Associacao Protectora dos Diabeticos de Portugal

    collaborator OTHER
  • The Algarve Regional Health Administration

    collaborator OTHER
  • University of Leipzig

    collaborator OTHER
  • Technische Universität Dresden

    collaborator OTHER
  • Alexander Technological Educational Institute, Thessaloniki, Greece

    collaborator OTHER
  • Diabetes Centre of Paediatrics P&A

    collaborator UNKNOWN
  • Primary Care Centre Egia, San Sebastian, Spain

    collaborator UNKNOWN
  • Basque Government Department of Public Health

    collaborator OTHER
  • Health Department of the Alto/Bajo Deba

    collaborator OTHER
  • University Hospitals, Leicester

    lead OTHER

Principal Investigators

  • Melanie J Davies, MD · University Hospitals, Leicester

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-03-31
Completion
2017-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02845791 on ClinicalTrials.gov